Clinical Trial Update: Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures [Phase 2]

View source ↗

Summary

Phase 2 trial update on liposomal bupivacaine for acute pain in hip and femur fractures (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Fractures

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Ian Elliott Brown | Conditions: Femoral Fractures | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21